SVA logo

Sinovac Biotech (SVA) Gross Margin

Annual Gross Margin

59.51%
+5.36%+9.90%

01 December 2023

SVA Gross Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Gross Margin

N/A

01 June 2024

SVA Quarterly Gross Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SVA Gross Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years-31.5%-
5 y5 years-33.3%-

SVA Gross Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-37.0%+9.9%
5 y5 years-37.0%+9.9%
alltimeall time-37.0%+1166.5%

Sinovac Biotech Gross Margin History

DateAnnualQuarterly
Dec 2023
59.51%(+9.9%)
-
Dec 2022
54.15%(-42.7%)
-
Dec 2021
94.47%(+8.8%)
-
Dec 2020
86.84%(+0.0%)
86.71%(-1.2%)
Sept 2020
-
87.78%(+2.6%)
June 2020
-
85.55%(-1.8%)
Mar 2020
-
87.13%(+2.6%)
Dec 2019
86.80%(-2.7%)
84.90%(+1.2%)
Sept 2019
-
83.92%(-7.3%)
June 2019
-
90.49%(+0.9%)
Mar 2019
-
89.66%(+2.6%)
Dec 2018
89.23%(+1.0%)
87.35%(-4.4%)
Sept 2018
-
91.37%(+6.3%)
June 2018
-
85.97%(-8.6%)
Mar 2018
-
94.11%(+28.1%)
Dec 2017
88.39%(+28.0%)
-
Dec 2016
69.08%(-5.0%)
73.46%(-8.3%)
Sept 2016
-
80.15%(-146.8%)
June 2016
-
-171.39%(-396.7%)
Mar 2016
-
57.77%(-15.5%)
Dec 2015
72.69%(-3.6%)
68.33%(+2.1%)
Sept 2015
-
66.90%(-18.7%)
June 2015
-
82.25%(+9.8%)
Mar 2015
-
74.93%(-5.4%)
Dec 2014
75.41%(+5.6%)
79.22%(+11.7%)
Sept 2014
-
70.92%(-5.4%)
June 2014
-
74.98%(-1.1%)
Mar 2014
-
75.80%(+5.0%)
Dec 2013
71.43%(+16.7%)
72.16%(+9.1%)
Sept 2013
-
66.14%(-15.1%)
June 2013
-
77.88%(+10.9%)
Mar 2013
-
70.23%(+26.3%)
Dec 2012
61.19%
55.60%(+5.7%)
Sept 2012
-
52.61%(-38.3%)
DateAnnualQuarterly
June 2012
-
85.31%(+37.1%)
Mar 2012
-
62.24%(+0.4%)
Dec 2011
62.83%(+25.8%)
62.01%(+9.1%)
Sept 2011
-
56.83%(-17.4%)
June 2011
-
68.84%(+5.3%)
Mar 2011
-
65.40%(-416.9%)
Dec 2010
49.95%(-34.4%)
-20.64%(-130.2%)
Sept 2010
-
68.26%(-17.5%)
June 2010
-
82.70%(+3.2%)
Mar 2010
-
80.12%(+15.6%)
Dec 2009
76.17%(-3.1%)
69.28%(-16.2%)
Sept 2009
-
82.68%(+1.8%)
June 2009
-
81.20%(+4.2%)
Mar 2009
-
77.95%(+24.4%)
Dec 2008
78.63%(-2.5%)
62.66%(-22.7%)
Sept 2008
-
81.05%(-3.7%)
June 2008
-
84.18%(-4.5%)
Mar 2008
-
88.18%(+29.1%)
Dec 2007
80.61%(+11.3%)
68.32%(-19.3%)
Sept 2007
-
84.71%(-1.2%)
June 2007
-
85.70%(+7.2%)
Dec 2006
72.44%(-0.4%)
-
June 2006
-
79.91%(+10.0%)
Dec 2005
72.74%(+4.0%)
72.62%(0.0%)
Sept 2005
-
72.62%(-0.5%)
June 2005
-
73.02%(-4.2%)
Dec 2004
69.97%(+13.3%)
76.22%(+23.6%)
Sept 2004
-
61.68%(-7.6%)
June 2004
-
66.75%(-20.5%)
Dec 2003
61.75%(+35.1%)
83.97%(+206.7%)
Sept 2003
-
27.38%
Apr 2002
45.69%(+44.5%)
-
Apr 2001
31.62%(-666.7%)
-
Apr 2000
-5.58%
-

FAQ

  • What is Sinovac Biotech annual gross profit margin?
  • What is the all time high annual gross margin for Sinovac Biotech?
  • What is the all time high quarterly gross margin for Sinovac Biotech?

What is Sinovac Biotech annual gross profit margin?

The current annual gross margin of SVA is 59.51%

What is the all time high annual gross margin for Sinovac Biotech?

Sinovac Biotech all-time high annual gross profit margin is 94.47%

What is the all time high quarterly gross margin for Sinovac Biotech?

Sinovac Biotech all-time high quarterly gross profit margin is 94.11%